Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
16.4M
-
Shares change
-
-123K
-
Total reported value, excl. options
-
$77.3M
-
Value change
-
-$783K
-
Number of buys
-
19
-
Number of sells
-
-31
-
Price
-
$4.71
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q3 2020
66 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q3 2020.
Apyx Medical Corp - Common Stock (APYX) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.4M shares
of 35M outstanding shares and own 46.92% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (3.39M shares), Archon Capital Management LLC (2.5M shares), BlackRock Inc. (2.23M shares), PURA VIDA INVESTMENTS, LLC (903K shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares), JPMORGAN CHASE & CO (607K shares), STATE STREET CORP (598K shares), Taylor Frigon Capital Management LLC (566K shares), RENAISSANCE TECHNOLOGIES LLC (560K shares), and ROYCE & ASSOCIATES LP (559K shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.